Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Neuberg

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remissionA S Freedman, D Neuberg, J G Gribben, et al.
Annals of Hematology|May 6, 2004
PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trialR M Stone, J De Angelo, I Galinsky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 1999
Autologous bone marrow transplantation after histologic transformation of indolent B cell malignanciesJ W Friedberg, D Neuberg, J G Gribben, et al.
Leukemia|April 28, 2012
Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequencyJ S Blackburn, S Liu, D M Raiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastomaS A Grupp, J W Stern, N Bunin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's diseaseK E Nichols, S Levitz, K E Shannon, et al.
Blood|December 1, 1996
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemiaT W McLean, S Ringold, D Neuberg, et al.
Blood|November 24, 1999
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphomaA S Freedman, D Neuberg, P Mauch, et al.
Leukemia|March 30, 2013
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cellsY Wei, R Chen, S Dimicoli, et al.
Bone Marrow Transplantation|July 23, 1998
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphomaR J Soiffer, A S Freedman, D Neuberg, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remissionA S Freedman, D Neuberg, J G Gribben, et al.
Annals of Hematology|May 6, 2004
PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trialR M Stone, J De Angelo, I Galinsky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 1999
Autologous bone marrow transplantation after histologic transformation of indolent B cell malignanciesJ W Friedberg, D Neuberg, J G Gribben, et al.
Leukemia|April 28, 2012
Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequencyJ S Blackburn, S Liu, D M Raiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastomaS A Grupp, J W Stern, N Bunin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's diseaseK E Nichols, S Levitz, K E Shannon, et al.
Blood|December 1, 1996
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemiaT W McLean, S Ringold, D Neuberg, et al.
Blood|November 24, 1999
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphomaA S Freedman, D Neuberg, P Mauch, et al.
Leukemia|March 30, 2013
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cellsY Wei, R Chen, S Dimicoli, et al.
Bone Marrow Transplantation|July 23, 1998
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphomaR J Soiffer, A S Freedman, D Neuberg, et al.
Pageof 12